The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies
about
Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy.Reduced immunogenicity of induced pluripotent stem cells derived from Sertoli cells.Stem cells for murine interstitial cells of cajal suppress cellular immunity and colitis via prostaglandin E2 secretion.Proceedings: human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the california population: evaluating matching in a multiethnic and admixed populationHuman Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1Induced Pluripotent Stem Cells for Traumatic Spinal Cord Injury.Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation.The 'sweet' spot of cellular pluripotency: protein glycosylation in human pluripotent stem cells and its applications in regenerative medicine.Avoiding immunological rejection in regenerative medicine.Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System.Cellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases.HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.Introduction to thematic minireview series: Development of human therapeutics based on induced pluripotent stem cell (iPSC) technology.Recent progress of national banking project on homozygous HLA-typed induced pluripotent stem cells in South Korea.Application of stem cell-derived retinal pigmented epithelium in retinal degenerative diseases: present and future.Development of a global network of induced pluripotent stem cell haplobanks.On the Viability and Potential Value of Stem Cells for Repair and Treatment of Central Neurotrauma: Overview and Speculations
P2860
Q33999335-275E8A03-F543-4B6D-BB96-6D2C5412B46FQ35234014-BD9924D0-ED3B-42C8-A982-658EEDA33A77Q35537116-A8380016-11D9-462A-A842-F36C72B88673Q35552111-23CF90D7-BB17-4422-BD3D-258D15D02698Q35624098-5392EBEC-2B51-4832-959A-6D5D6A6CE6DAQ37592612-F2BF04E2-C15E-4DB8-A586-31B0E75FCF86Q38202011-7BD27834-CB7F-4436-A272-0E28D721FBBEQ38367341-744CFCC4-83D1-410F-8F6B-C0BC8235F5A7Q38453650-64DD8987-535B-4D7D-87DF-667371803167Q38864756-CD083B00-76C2-4606-80EA-9694417C50EBQ41572871-DD38B747-A29B-441A-A22A-AA15C4C1CB5DQ42376158-D077E5A2-23F8-4E2C-85E0-D5ACC3FEE8A7Q42434697-97C8F4D0-940D-4FD1-B138-3ADB5EE7C9C4Q47262237-5D60F9ED-A0E0-4CAC-9476-F76588ACF75EQ47708333-E8CA7DA0-08AF-410F-A62B-5F0A5ADF3329Q48039449-ABFFB5D2-8A78-48BA-BD29-9826622A425AQ58785850-D01BC769-1B17-4E6A-BFCA-DDC3C8EA8928
P2860
The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The potential for immunogenici ...... nt stem cell-derived therapies
@ast
The potential for immunogenici ...... nt stem cell-derived therapies
@en
The potential for immunogenici ...... nt stem cell-derived therapies
@nl
type
label
The potential for immunogenici ...... nt stem cell-derived therapies
@ast
The potential for immunogenici ...... nt stem cell-derived therapies
@en
The potential for immunogenici ...... nt stem cell-derived therapies
@nl
prefLabel
The potential for immunogenici ...... nt stem cell-derived therapies
@ast
The potential for immunogenici ...... nt stem cell-derived therapies
@en
The potential for immunogenici ...... nt stem cell-derived therapies
@nl
P2093
P2860
P356
P1476
The potential for immunogenici ...... nt stem cell-derived therapies
@en
P2093
E. G. Feigal
Z. S. Scheiner
P2860
P304
P356
10.1074/JBC.R113.509588
P407
P577
2014-02-21T00:00:00Z